Optimind Pharma Corp.
OMND
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.60K | -60.30K | -71.50K | -525.50K | -76.50K |
| Total Depreciation and Amortization | -- | -- | -- | 0.00 | 3.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 426.30K | 6.50K |
| Change in Net Operating Assets | 15.40K | -177.50K | 157.70K | 96.80K | 60.90K |
| Cash from Operations | 8.80K | -237.80K | 86.20K | -2.40K | -5.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -200.00 | -11.40K |
| Cash from Investing | -- | -- | -- | -200.00 | -11.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -7.60K |
| Issuance of Common Stock | 0.00 | 270.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 197.20K | -- | 0.00 | -5.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.80K | -40.70K | 86.20K | -2.50K | -22.40K |
